Results 31 to 40 of about 11,189 (206)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2

open access: yesОжирение и метаболизм, 2011
Bromocriptine is a sympatholytic agonist of dopamine receptors, which is now proposed for treatment of type 2 diabetes mellitus. In animal studies bromocriptine elevates the decreased levels of dopamine in hypothalamus and blocks excessive sympathetic ...
O. A. Gerasimenko   +2 more
doaj   +1 more source

Effects of Bromocriptine on Dopamine Turnover with or without Levodopa [PDF]

open access: yes, 1996
Bromocriptine, a dopamine agonist, alleviates symptoms of Parkinson's disease, even when administered alone, and is used for its treatment. Better therapeutic effects are, however, achieved when bromocriptine is used in combination with levodopa.
M Asanvma   +5 more
core   +1 more source

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control

open access: yesJournal of Pharmacy and Bioallied Sciences, 2010
Food and Drug Administration (FDA) approved bromocriptine mesylate, a quick release formulation, 0.8 mg tablets, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Yogendra Keche
doaj   +1 more source

Severe Hypoglycemia Due To the Administration of Bromocriptine in a Non-Diabetic Patient: A Case Study

open access: yesCase Reports in Clinical Practice, 2020
The patient was a 24-year-old man with persistent vegetative state following severe traumatic brain injury due to a car accident, who was referred to the emergency department with a generalized tonic-clonic seizure due to severe hypoglycemia. The patient
Saeed Choobkar   +2 more
doaj   +1 more source

Bromocriptine for idiopathic oligo/asthenospermia. [PDF]

open access: yes, 2000
Oligo-astheno-teratospermia (sperm of low concentration, reduced motility and increased abnormal morphology)of unknown cause is common and the need for treatment is felt by patients and doctors alike.
Vail, A.; id_orcid   +3 more
core   +2 more sources

Akinetic mutism related to hydrocephalus and cerebellar surgery treated with bromocriptine and ephedrine. A pathophysiological review [PDF]

open access: yes, 2005
Akinetic mutism (AM) is a behavioral disorder characterized by impossibility to move or speak in awake patients. lt has been typically described as a transient disorder following posterior fossa tumour resection.
Iza, Begoña   +6 more
core   +1 more source

Bromocriptine in the Management of Central Hyperthermia [PDF]

open access: yes
Central fever, or hyperthermia of central origin, is a not so rare cause of hyperthermia in neurological rehabilitation units, characterised by persistent fever without any recognisable cause, and poor response to conventional antipyretics.
Atiq Rehman   +3 more
core   +1 more source

The regulatory effect of bromocriptine on cardiac hypertrophy by prolactin and D2 receptor modulation

open access: yesClinical and Experimental Hypertension, 2020
Background Bromocriptine, a dopamine agonist, used for the treatment of hyperprolactinemia, type 2 diabetes, ovarian hyper-stimulation syndrome, has also effects on the cardiac remodeling process, but the mechanism of action is unknown.
Karla Aidee Aguayo-Cerón   +4 more
doaj   +1 more source

Bromocriptine-induced reduction of body fat in pigs. [PDF]

open access: yes, 1990
An experiment was conducted with 36 crossbred finishing pigs (18 male castrates and 18 females) to evaluate the effect of bromocriptine implants on growth, feed intake, feed efficiency, plasma urea nitrogen (PUN) and carcass characteristics. Three levels
Meier, A. H.   +4 more
core   +1 more source

Impact of ergot alkaloid and steroidal implant on whole-body protein turnover and expression of mTOR pathway proteins in muscle of cattle

open access: yesFrontiers in Veterinary Science, 2023
IntroductionHolstein steers (n = 32) were used to determine if the ergot analog, bromocriptine decreases muscle protein synthesis through inhibitory action on the mTOR pathway via a direct effect on signal proteins, and if these negative effects can be ...
Taylor D. Ferguson   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy